Biology Reference
In-Depth Information
69. Mishra PJ, Banerjee D, Bertino JR (2008) MiRSNPs or MiR-polymorphisms, new players in
microRNA mediated regulation of the cell: introducing microRNA pharmacogenomics. Cell
Cycle 7(7):853-858
70. Adams BD, Furneaux H, White BA (2007) The micro-ribonucleic acid (miRNA) miR-206
targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA
and protein expression in breast cancer cell lines. Mol Endocrinol 21(5):1132-1147
71. He H et al (2005) The role of microRNA genes in papillary thyroid carcinoma. Proc Natl
Acad Sci USA 102(52):19075-19080
72. Gao P et al (2009) c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase
expression and glutamine metabolism. Nature 458(7239):762-765
73. Velu CS, Baktula AM, Grimes HL (2009) Gfi1 regulates miR-21 and miR-196b to control
myelopoiesis. Blood 113(19):4720-4728
74. Yan HL et al (2009) Repression of the miR-17-92 cluster by p53 has an important function in
hypoxia-induced apoptosis. EMBO J 28(18):2719-2732
75. Suh SO et al (2011) MicroRNA-145 is regulated by DNA methylation and p53 gene mutation
in prostate cancer. Carcinogenesis 32(5):772-778
76. Guil S, Esteller M (2009) DNA methylomes, histone codes and miRNAs: tying it all together.
Int J Biochem Cell Biol 41(1):87-95
77. Weber B et al (2007) Methylation of human microRNA genes in normal and neoplastic cells.
Cell Cycle 6(9):1001-1005
78. Lehmann U et al (2008) Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human
breast cancer. J Pathol 214(1):17-24
79. Saito Y et al (2006) Specific activation of microRNA-127 with downregulation of the proto-
oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell
9(6):435-443
80. Thomson JM et al (2006) Extensive post-transcriptional regulation of microRNAs and its
implications for cancer. Genes Dev 20(16):2202-2207
81. Melo SA et al (2010) A genetic defect in exportin-5 traps precursor microRNAs in the nucleus
of cancer cells. Cancer Cell 18(4):303-315
82. Yang W et al (2006) Modulation of microRNA processing and expression through RNA edit-
ing by ADAR deaminases. Nat Struct Mol Biol 13(1):13-21
83. Kawahara Y et al (2007) RNA editing of the microRNA-151 precursor blocks cleavage by the
Dicer-TRBP complex. EMBO Rep 8(8):763-769
84. Kawahara Y et al (2007) Redirection of silencing targets by adenosine-to-inosine editing of
miRNAs. Science 315(5815):1137-1140
85. Deng S et al (2008) Mechanisms of microRNA deregulation in human cancer. Cell Cycle
7(17):2643-2646
86. Fabbri M (2010) miRNAs as molecular biomarkers of cancer. Expert Rev Mol Diagn
10(4):435-444
87. Ferracin M, Veronese A, Negrini M (2010) Micromarkers: miRNAs in cancer diagnosis and
prognosis. Expert Rev Mol Diagn 10(3):297-308
88. Munker R, Calin GA (2011) MicroRNA profiling in cancer. Clin Sci (Lond) 121(4):141-158
89. Rosenfeld N et al (2008) MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol
26(4):462-469
90. Ferdin J, Kunej T, Calin GA (2010) Non-coding RNAs: identification of cancer-associated
microRNAs by gene profiling. Technol Cancer Res Treat 9(2):123-138
91. Kong W et al (2009) Strategies for profiling microRNA expression. J Cell Physiol
218(1):22-25
92. Liu CG et al (2004) An oligonucleotide microchip for genome-wide microRNA profiling in
human and mouse tissues. Proc Natl Acad Sci USA 101(26):9740-9744
93. Liu CG et al (2008) Expression profiling of microRNA using oligo DNA arrays. Methods
44(1):22-30
94. Yin JQ, Zhao RC, Morris KV (2008) Profiling microRNA expression with microarrays.
Trends Biotechnol 26(2):70-76
Search WWH ::
Custom Search